Immune fitness and response to taclistamab in R/R multiple myeloma; BCR::ABL1 M244V mutation causes resistance to asciminib; HSCT and myocardial fibrosis in young patients with SCD

In this week's episode we’ll discuss how immune fitness impacts response to teclistamab in relapsed/refractory multiple myeloma; learn more about a new mechanism of resistance to asciminib conferred by the BCR::ABL1 M244V mutation, and discuss the impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease.

Featured Articles:

• Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1
• BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib
• Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease

What is Blood Podcast?

The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.